NZTE is a genuinely useful starting point for a New Zealand company eyeing the US, and I recommend founders use it. It is also widely misunderstood. Founders sometimes treat NZTE support as if it answers the central US-entry question, and it isn't designed to. Here is what NZTE actually provides, including the funding, and the one thing it does not do.
NZTE is the government's export development agency, and it supports over 5,000 New Zealand exporters a year across 100 markets. For a US move, the useful parts are:
Market intelligence and guides through the myNZTE portal: importing rules, market research, and country guides.
In-market connections: NZTE has people in US offices who can make introductions to buyers, partners, and networks.
Capability building: workshops, tools, and advice on export readiness.
Independent advice on raising capital and financial guidance.
The International Growth Fund: a contestable co-investment programme for high-impact international growth projects. This is the funding founders ask about. It is limited, prioritises projects with clear benefit to New Zealand (job creation, domestic spend, shareholder returns), and only NZTE Focus customers may be invited to apply. Projects must go well beyond business as usual to qualify.
If you are exporting or planning to within 12 to 18 months, engaging NZTE early is worth doing. The access and the co-funding are real.
NZTE gives you access, introductions, market information, and in some cases co-funding. It does not resolve whether your commercial model survives US economics.
NZTE will not tell you that your US price should be 4 times your NZ price, or that your unit economics break at US customer acquisition costs, or that the channel you're about to pick will lock you out of your own customers, or that you should delay entry by a year because the model isn't ready. Those are founder-level commercial decisions specific to your business, and a broad export agency serving 5,000 companies is not structured to make them for any one of them.
That gap is not a criticism of NZTE. It is a different job. NZTE opens the door. Whether your business survives once it walks through is a separate question, and it is the one that determines whether the money you spend on entry earns anything back.
The founders who do this well use NZTE for what it is strong at (access, market intelligence, connections, and co-funding) and get the commercial architecture (pricing, first buyer, channel, unit economics, sequencing, go or no-go) resolved separately, before they commit capital. The two fit together. One gets you into the market. The other decides whether you should go, and what has to be true first.
FREQUENTLY ASKED
Does NZTE help New Zealand companies expand to the US?
Yes. NZTE provides market intelligence, in-market introductions, export capability support, financial guidance, and co-investment through the International Growth Fund for eligible Focus customers.
What is the NZTE International Growth Fund?
A contestable co-investment programme for high-impact international growth projects. It is limited, prioritises clear benefit to New Zealand, and only NZTE Focus customers may be invited to apply, with projects required to go well beyond business as usual.
What does NZTE not help with?
NZTE provides access and information, not founder-level commercial decisions. It does not resolve your US pricing, unit economics, channel choice, or whether your specific business model survives US costs.
NZTE programmes and eligibility change. Confirm current details directly with NZTE at nzte.govt.nz.
A missing Puzzle piece
The US Market Entry Diagnostic answers the question NZTE isn't built to: does your commercial model survive US economics, and should you go, delay, or redesign. You leave with a direct answer. Use NZTE for access. Use the Diagnostic for the decision.
Book a US Market Entry Diagnostic